Viewing Study NCT04678466


Ignite Creation Date: 2025-12-24 @ 4:39 PM
Ignite Modification Date: 2026-02-20 @ 6:41 PM
Study NCT ID: NCT04678466
Status: NO_LONGER_AVAILABLE
Last Update Posted: 2022-05-31
First Post: 2020-12-16
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Flotetuzumab Expanded Access Program
Sponsor: MacroGenics
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Acute Myeloid Leukemia View
None AML View
None AML, Adult Recurrent View
Keywords: